Planned Health Spinout with Lilly Backing

Kura Oncology has a planned spinout backed by Lilly. This health initiative represents a forward step in diabetes therapy development. However, the source is unreachable and no specific details about

Kura Oncology has a planned spinout backed by Lilly. This health initiative represents a forward step in diabetes therapy development. However, the source is unreachable and no specific details about the therapy’s progress or funding are confirmed. The potential for future affordable treatments remains unverified.

Source: Fierce Biotech